The developing HPV-driven tumor cells can upregulate immune checkpoint molecules, such as PD-1/PDL1, and CTLA-4, which negatively regulate cytotoxic T cells, blocking anti-tumour specific responses. The gene discussed is CTLA4; the disease is neoplasm.